Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study

Table 2 Clinical parameter comparisons between baseline and post

Clinical Parameters (Mean ± SD)	Statin Group Paired Diff.^a (N = 10,104)	Comparison Group Paired Diff.^a (N = 10,104)	Diff. in diff. (Statin Group - Comparison Group)	P-value
HbA1c, %	−0.18 ± 1.31	−0.21 ± 1.29	0.02	0.223
SBP, mmHg	−5.31 ± 19.81	−3.28 ± 19.20	−2.03	< 0.001*
DBP, mmHg	−4.06 ± 10.89	−1.96 ± 10.49	−2.09	< 0.001*
LDL-C, mmol/L	−1.47 ± 0.79	−0.26 ± 0.64	−1.21	< 0.001*
TC/ HDL-C Ratio	−1.39 ± 0.99	−0.40 ± 1.04	−1.00	< 0.001*
Triglyceride, mmol/L	−0.25 ± 0.75	−0.12 ± 0.79	−0.14	< 0.001*
BMI, kg/m²	−0.25 ± 1.81	−0.26 ± 1.62	0.01	0.699

HbA1c Haemoglobin A1c, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, LDL-C Low Density Lipoprotein - Cholesterol, TC Total Cholesterol, HDL-C High Density Lipoprotein - Cholesterol, BMI Body Mass Index
*Significant with p-value <0.05 by independent t-test
^aPaired difference (Post - baseline)

ISSN: 1471-2261